Application of drug-coated balloon in femoropopliteal artery occlusive disease
10.3760/cma.j.issn.1007-631X.2018.09.018
- VernacularTitle:药物涂层球囊在股腘动脉硬化闭塞症治疗中的应用
- Author:
Xiaoyang NIU
1
;
Bing WANG
;
Fei WU
;
Yang LI
;
Guanghua WANG
;
Likun SUN
;
Xiaozhe LIU
Author Information
1. 450052,郑州大学第五附属医院血管外科
- Keywords:
Arterial occlusive diseases;
Angioplasty,balloon;
Femoropopliteal artery
- From:
Chinese Journal of General Surgery
2018;33(9):772-775
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the efficacy of drug-coated balloon in treatment of femoropopliteal artery occlusive disease.Methods The clinical data of 49 patients with femoropopliteal artery occlusive disease from Feb 2016 to Oct 2017 were retrospectively analyzed.25 cases underwent drugcoated balloon treatment (DCB group),and 24 cases received plain balloon angioplasty (POBA group).Results The procedures were successful in all cases.There were no amputation or death occurred.In DCB group compared to POBA group,the patency rate at postoperative 3 months were not significantly different (96.0％ vs.87.5％,P ＞ 0.05),while it was significantly different at postoperative 6 and 12 months (88.0％ vs.66.7％;80.0％ vs.50.0％,both P ＜0.05).Minimal lumen diameter (MLD) changes and late lumen loss(LLL):The MLD in preoperative,immediate postoperative was not statistically significant between the three group(P ＞ 0.05).At 6 months and 12 months after operation,MLD of DCB group was higher than POBA group (P ＜ 0.05).At 12 months after surgery,LLL in DCB group was significantly lower than the POBA group (P ＜ 0.05).Conclusion DCB is the effective method to treat femoropopliteal artery occlusive disease,which has better short and mid-term efficacy than POBA.
